Trials / Completed
CompletedNCT01992380
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
Test-Retest Reproducibility of 18F-AV-1451 Injection for Brain Imaging of Tau in Healthy Volunteers and Cognitively Impaired Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
This study will test if two flortaucipir PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | IV injection, 370 MBq (10 mCi), two doses up to four weeks apart |
| PROCEDURE | Brain PET scan | positron emission tomography (PET) scan of the brain at 80-100 and 110-130 minutes after injection |
Timeline
- Start date
- 2013-11-13
- Primary completion
- 2014-05-30
- Completion
- 2014-05-30
- First posted
- 2013-11-25
- Last updated
- 2020-09-07
- Results posted
- 2020-09-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01992380. Inclusion in this directory is not an endorsement.